Back

AchieveCE

  • Antithyroid Agents
  • Graves Disease
  • Graves Ophthalmopathy

Graves Disease Update: Diagnostic Biomarkers, Biologics, and Treatment Strategies

This course reviews the clinical evaluation and management of Graves disease. It covers key autoimmune mechanisms, standard testing approaches for confirming etiology, and practical decision points that affect treatment selection. The course also addresses antithyroid drug use and monitoring considerations, definitive treatment options, and major complications that may require urgent recognition and escalation of care. Special considerations discussed include pregnancy-related management and thyroid eye disease. Clinical practice varies in how Graves disease is confirmed, how ongoing management decisions are made over time, and how complications are recognized and addressed. Some clinicians may be unfamiliar with newer testing approaches, emerging therapies, and patient-centered tools that support shared decision-making. This activity is designed to strengthen consistency in evaluation, treatment planning, monitoring, and complication readiness for Graves disease across routine and urgent care settings.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

$23

Standard

Listed by the provider · achievece.com

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • $23
  • Released
    Mar 23, 2026
  • Last day to claim credit
    Mar 24, 2029 2 years left